Bristol Myers Squibb Foundation

Diversifying Clinical Trials: A Global Initiative With Local Roots


Increasing diversity in clinical trials (DiCT) is imperative to improve the health of populations around the world. Everyone has the right to achieve optimal health outcomes — that’s the core of what health equity means. Without including representative populations in clinical trials, diverse groups are unable to participate in the development of critical, often life-saving, therapies — exacerbating inequities and creating new ones.

Encouraging Recruitment of Diverse Talent in the Biopharma Industry


By Tunde Bello

I am a Black British man with an African name living in the United States. There are many times when I feel that I alone represent a whole group of people. I felt the weight of that responsibility every day when I started my career in drug development because in most meetings, I was the only person of color.

The Bristol Myers Squibb Foundation Diversity in Clinical Trials Career Development Program Announces First Group of Physicians to Be Trained

52 physicians from across the U.S. selected for the inaugural cohort of the five-year, $100 million initiative
Press Release

PRINCETON, N.J., October 22, 2021 /3BL Media/ - The Bristol Myers Squibb Foundation (BMSF), together with its partners, National Medical Fellowships (NMF) and the American Association for Cancer Research (AACR), today announced th

Bristol Myers Squibb Matches Employee-led Donations to Community

Multimedia with summary

Last year, our employee-led People & Business Resource Groups identified impactful organizations fighting disparities and discrimination. When U.S. and Puerto Rico-based employees donate to these selected groups, the Bristol Myers Squibb Foundation double-matches their gifts. Learn more about this special Employee Giving program.

The Bristol Myers Squibb Foundation Announces First Global Cancer Disparities Grants in Brazil

Four projects in Brazil receive inaugural grants to improve delivery of care for lung cancer and melanoma patients
Press Release

NEW YORK, May 25, 2021 /3BL Media/ - The Bristol Myers Squibb Foundation has launched a new initiative in Brazil, awarding four grants aimed at improving the delivery of high-quality care for lung cancer and skin cancer to medically underserved and rural communities. The organizations that have received grants are focused on community outreach and disease education, strengthening collaborations among primary care physicians and oncologists, and supporting efforts to promote early diagnosis and treatment.

Bristol Myers Squibb and the Bristol Myers Squibb Foundation Commit $300 Million to Accelerate and Expand Health Equity and Diversity and Inclusion Efforts

Five–year commitment builds on long-standing investment in health equity
Press Release

PRINCETON, N.J., AUGUST 12, 2020) /3BL Media/ - Bristol Myers Squibb (NYSE: BMY) and the Bristol Myers Squibb Foundation announced today a combined investment of $300 million as part of a series of commitments.

LLS and Partners Commit $4.5 Million for Blood Cancer Patients Impacted by COVID-19

LLS Sets Goal of Raising $10 Million from Partners and Donors for New LLS COVID-19 Patient Financial Aid Program Launching April 1

In the wake of the COVID-19 pandemic, The Leukemia & Lymphoma Society (LLS), a global leader in the fight against cancer, along with valued partners, announced their commitment to help as many blood cancer patients as possible during this unprecedented crisis. The LLS COVID-19 Patient Financial Aid Program will begin immediately to provide $250 to eligible patients struggling with the economic hardship presented by the pandemic.

Subscribe to Bristol Myers Squibb Foundation